Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Hematology/Oncology

RSS  

Articles

  • Q&A education tool for patients on isolation

    The following questions and answers are summarized with permission from an educational brochure developed at Duke University Medical Center in Durham, NC, for patients who are being placed in contact isolation:
  • Use this CDC guidance when no SARS is in facility

    Draft guidelines by the Centers for Disease Control and Prevention ratchet up increasing infection control and administrative measures depending on whether severe acute respiratory syndrome (SARS) has appeared globally, within a community, or within a facility.
  • What’s the C-difference? Oh, $15,000 an infection

    Editors note: As this issue of Hospital Infection Control went to press, these studies were presented in Chicago at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Look for more in-depth coverage of this conference in our next issue
  • Duke ICPs work to remove stigma of patient isolation

    There is an increasing emphasis in infection control on doing active surveillance cultures and detecting and isolating patients colonized with pathogens such as vancomycin-resistant enterococci (VRE).
  • CDC balks at linking SARS and flu shots

    Diverging from the position taken by the Geneva-based World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC) will not urge influenza vaccination for the 2003-2004 season specifically as a response to the possible return of severe acute respiratory syndrome (SARS), Hospital Infection Control has learned.
  • CDC draft urges universal masking of incoming patients to prevent SARS

    Draft guidance by public health officials preparing for a seasonal resurgence of severe acute respiratory syndrome (SARS) calls for taking the controversial step of masking all incoming patients with respiratory symptoms, Hospital Infection Control has learned.
  • Clinical Briefs in Primary Care Supplement

    Prognostic Value of ABPMs in patients with Treated Hypertension; Tazarotene Cream in the Treatment of Psoriasis; Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes; Metformin and Thiazolidinedione Use in Medicare Patients with Heart Failure; Alcohol Consumption Patterns and Biologic Markers of Glycemic Control; Azelaic Acid Gel as a New Treatment for Papulopustular Rosacea
  • Full September 2003 Issue in PDF

  • A Critical Appraisal of Dyslipidemia Therapy

    Based on a patients lipoprotein abnormality, the algorithm described in this review begins with achievable, practical therapeutic lifestyle changes and then adds pharmacologic agents in stepwise fashion to address abnormalities of LDL cholesterol, triglycerides, and HDL cholesterol. While the approach is aggressive, it is not based on driving lipid levels to extremely low levels. While some of the lipid targets appear less stringent than conventional wisdom would suggest (eg, accepting an LDL cholesterol target of 130 mg/dL), the approach is in compliance with the spirit and letter of national guidelines.
  • Do Anaerobic Bacteria Cause Ventilator-Associated Pneumonia?

    Of 26 mechanically ventilated patients, 22 developed bacterial lower respiratory tract colonization, and in 15 patients anaerobes were recovered; 2 of 5 patients diagnosed with ventilator-associated pneumonia had anaerobes present in sufficient quantity to suggest that they were considered pathogenic.